Literature DB >> 12823905

Evaluation of a new Aerodynamic Particle Sizer Spectrometer for size distribution measurements of solution metered dose inhalers.

Stephen W Stein1, Paul B Myrdal, Brian J Gabrio, Derek Obereit, Tyler J Beck.   

Abstract

The ability of the Model 3320 and newer Model 3321 Aerodynamic Particle Sizer Spectrometer (APS) to make accurate mass-weighted size distribution measurements of solution metered dose inhalers (MDIs) was evaluated. Measurements of experimental HFA-134a beclomethasone dipropionate MDIs were made with both the APS 3320 and APS 3321 and compared to the Andersen Cascade Impactor (ACI). The mass-weighted size distribution measurements from the ACI and APS 3321 agreed well but were very different than the APS 3320 measurements. Evaluation of the APS 3320 size distribution measurements indicated that the presence of a few erroneous particle measurements caused a gross overestimation of the mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD). When a previously described technique was used to eliminate erroneous particle size measurements from the size distribution calculation, the MMAD and GSD from the APS 3320 agreed well with those from the ACI and APS 3321. The GSD from the APS 3321 and the APS 3320 after a mask was applied were slightly larger than from the ACI. It is believed that both APS instruments slightly underestimate the GSD while the ACI slightly overestimates the GSD. Further experiments were conducted using the APS 3321 to examine the influence of drug concentration and cosolvent level on the size distribution of solution formulation MDIs. The MMAD was shown experimentally and theoretically to be proportional to drug concentration to the one-third power. Cosolvent concentration had minimal influence on MMAD over the range examined. The measurements reported in this paper demonstrate that it is possible to obtain accurate mass-weighted size distribution measurements with the APS 3320 and APS 3321. These instruments allow for accurate size distribution measurements to be made in minutes as opposed to the hours required to conduct and analyze size distribution measurements from cascade impactors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823905     DOI: 10.1089/089426803321919870

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  7 in total

1.  Applicability of an ultrasonic nebulization system for the airways delivery of beclomethasone dipropionate in a murine model of asthma.

Authors:  Boska Hrvacić; Berislav Bosnjak; Marijan Tudja; Milan Mesić; Mladen Merćep
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

2.  Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers.

Authors:  Julie A Harris; Stephen W Stein; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

3.  Inhalation of an ethanol-based zileuton formulation provides a reduction of pulmonary adenomas in the A/J mouse model.

Authors:  Kelly L Karlage; Erik Mogalian; Annikka Jensen; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2010-01-26       Impact factor: 3.246

4.  A novel aerodynamic sizing method for pharmaceutical aerosols using image-based analysis of settling velocities.

Authors:  Rami Fishler; Josué Sznitman
Journal:  Inhalation       Date:  2017-06

5.  Particle sizing of pharmaceutical aerosols via direct imaging of particle settling velocities.

Authors:  Rami Fishler; Frank Verhoeven; Wilbur de Kruijf; Josué Sznitman
Journal:  Eur J Pharm Sci       Date:  2017-08-16       Impact factor: 4.384

6.  Laboratory Evaluation of the Shinyei PPD42NS Low-Cost Particulate Matter Sensor.

Authors:  Elena Austin; Igor Novosselov; Edmund Seto; Michael G Yost
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

7.  Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation.

Authors:  Ditte Marie Krohn Jensen; Dongmei Cun; Morten Jonas Maltesen; Sven Frokjaer; Hanne Mørck Nielsen; Camilla Foged
Journal:  J Control Release       Date:  2009-10-22       Impact factor: 9.776

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.